• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020 年 2 月至 2022 年 5 月期间,挪威基于两个登记系统对因 COVID-19 住院患者的监测比较。

A comparison of two registry-based systems for the surveillance of persons hospitalised with COVID-19 in Norway, February 2020 to May 2022.

机构信息

Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.

Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway.

出版信息

Euro Surveill. 2023 Aug;28(33). doi: 10.2807/1560-7917.ES.2023.28.33.2200888.

DOI:10.2807/1560-7917.ES.2023.28.33.2200888
PMID:37589591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10436689/
Abstract

BackgroundThe surveillance of persons hospitalised with COVID-19 has been essential to ensure timely and appropriate public health response. Ideally, surveillance systems should distinguish persons hospitalised with COVID-19 from those hospitalised due to COVID-19.AimWe compared data in two national electronic health registries in Norway to critically appraise and inform the further development of the surveillance of persons hospitalised with COVID-19.MethodWe included hospitalised COVID-19 patients registered in the Norwegian Patient Registry (NPR) or the Norwegian Pandemic Registry (NoPaR) with admission dates between 17 February 2020 and 1 May 2022. We linked patients, identified overlapping hospitalisation periods and described the overlap between the registries. We described the prevalence of International Classification of Diseases (ICD-10) diagnosis codes and their combinations by main cause of admission (clinically assessed as COVID-19 or other), age and time.ResultsIn the study period, 19,486 admissions with laboratory-confirmed COVID-19 were registered in NoPaR and 21,035 with the corresponding ICD-10 code U07.1 in NPR. Up to late 2021, there was a 90-100% overlap between the registries, which thereafter decreased to < 75%. The prevalence of ICD-10 codes varied by reported main cause, age and time.ConclusionChanges in patient cohorts, virus characteristics and the management of COVID-19 patients from late 2021 impacted the registration of patients and coding practices in the registries. Using ICD-10 codes for the surveillance of persons hospitalised due to COVID-19 requires age- and time-specific definitions and ongoing validation to consider temporal changes in patient cohorts and virus characteristics.

摘要

背景

对 COVID-19 住院患者的监测对于确保及时和适当的公共卫生反应至关重要。理想情况下,监测系统应区分因 COVID-19 住院的患者和因 COVID-19 而住院的患者。

目的

我们比较了挪威两个国家电子健康注册中心的数据,以批判性地评估和为 COVID-19 住院患者监测的进一步发展提供信息。

方法

我们纳入了 2020 年 2 月 17 日至 2022 年 5 月 1 日期间在挪威患者登记处(NPR)或挪威大流行登记处(NoPaR)登记的 COVID-19 住院患者。我们对患者进行了链接,确定了重叠的住院期,并描述了两个登记处之间的重叠。我们描述了按主要入院原因(临床评估为 COVID-19 或其他)、年龄和时间划分的国际疾病分类(ICD-10)诊断代码及其组合的患病率。

结果

在研究期间,NoPaR 登记了 19486 例经实验室确诊的 COVID-19 住院患者,NPR 登记了 21035 例对应的 ICD-10 代码 U07.1。直到 2021 年底,两个登记处之间的重叠率为 90-100%,此后降至<75%。ICD-10 代码的患病率因报告的主要原因、年龄和时间而异。

结论

2021 年底以来,患者队列、病毒特征和 COVID-19 患者的管理变化影响了登记处的患者登记和编码做法。使用 ICD-10 代码对因 COVID-19 住院的患者进行监测需要针对年龄和时间的特定定义和持续验证,以考虑患者队列和病毒特征的时间变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdd/10436689/9ff44bec910e/2200888-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdd/10436689/ff180048807b/2200888-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdd/10436689/7a3544324b0e/2200888-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdd/10436689/57b7fe216dbe/2200888-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdd/10436689/9ff44bec910e/2200888-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdd/10436689/ff180048807b/2200888-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdd/10436689/7a3544324b0e/2200888-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdd/10436689/57b7fe216dbe/2200888-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdd/10436689/9ff44bec910e/2200888-f4.jpg

相似文献

1
A comparison of two registry-based systems for the surveillance of persons hospitalised with COVID-19 in Norway, February 2020 to May 2022.2020 年 2 月至 2022 年 5 月期间,挪威基于两个登记系统对因 COVID-19 住院患者的监测比较。
Euro Surveill. 2023 Aug;28(33). doi: 10.2807/1560-7917.ES.2023.28.33.2200888.
2
The incidence of hip fractures in Norway -accuracy of the national Norwegian patient registry.挪威髋部骨折的发病率——挪威国家患者登记处的准确性
BMC Musculoskelet Disord. 2014 Nov 13;15:372. doi: 10.1186/1471-2474-15-372.
3
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
4
Hospitalisations for COVID-19 - a comparison of different data sources.新型冠状病毒肺炎(COVID-19)住院情况——不同数据来源的比较
Tidsskr Nor Laegeforen. 2020 Dec 14;140(18). doi: 10.4045/tidsskr.20.0759. Print 2020 Dec 15.
5
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.2020 年 12 月至 2021 年 5 月期间,在挪威报告的 SARS-CoV-2 变异株 B.1.1.7 和 B.1.351 与住院和重症监护入院风险增加相关。
PLoS One. 2021 Oct 11;16(10):e0258513. doi: 10.1371/journal.pone.0258513. eCollection 2021.
6
Validity of ICD-10 codes for COVID-19 patients with hospital admissions or ED visits in Canada: a retrospective cohort study.加拿大新冠病毒疾病患者住院或急诊就诊时国际疾病分类第十版编码的有效性:一项回顾性队列研究
BMJ Open. 2022 Jan 21;12(1):e057838. doi: 10.1136/bmjopen-2021-057838.
7
Deaths after confirmed SARS-CoV-2 in Norway.挪威确诊感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)后的死亡情况。
Tidsskr Nor Laegeforen. 2020 Dec 3;140(18). doi: 10.4045/tidsskr.20.0693. Print 2020 Dec 15.
8
SARS-CoV-2 in children and adolescents in Norway: confirmed infection, hospitalisations and underlying conditions.挪威儿童和青少年中的新型冠状病毒肺炎:确诊感染、住院情况及潜在疾病
Tidsskr Nor Laegeforen. 2020 Jun 24;140(11). doi: 10.4045/tidsskr.20.0457. Print 2020 Aug 18.
9
Validation of diagnosis codes to identify hospitalized COVID-19 patients in health care claims data.验证诊断代码以在医疗保健索赔数据中识别住院的 COVID-19 患者。
Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):476-480. doi: 10.1002/pds.5401. Epub 2022 Jan 3.
10
Neuroborreliosis in patients hospitalised for Lyme borreliosis in the Czech Republic in 2003 - 2013.2003年至2013年在捷克共和国因莱姆病住院患者中的神经型莱姆病
Epidemiol Mikrobiol Imunol. 2017 Fall;66(3):115-123.

引用本文的文献

1
Surveillance of severe acute respiratory infections associated with SARS-CoV-2, influenza virus and RSV using ICD-10 codes: a case definition accuracy study across five European countries, 2021 to 2023.使用国际疾病分类第10版(ICD-10)编码对与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)、流感病毒和呼吸道合胞病毒(RSV)相关的严重急性呼吸道感染进行监测:2021年至2023年五个欧洲国家的病例定义准确性研究
Euro Surveill. 2025 Jul;30(27). doi: 10.2807/1560-7917.ES.2025.30.27.2400748.
2
Characteristics of influenza, SARS-CoV-2, and RSV surveillance systems that utilise ICD-coded data: a systematic review.利用国际疾病分类编码数据的流感、新冠病毒和呼吸道合胞病毒监测系统的特征:一项系统综述
J Glob Health. 2025 May 23;15:04177. doi: 10.7189/jogh.15.04177.
3

本文引用的文献

1
The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19.变异株和疫苗接种对 COVID-19 住院患者病死率和资源利用的影响。
BMC Infect Dis. 2022 Aug 22;22(1):702. doi: 10.1186/s12879-022-07657-z.
2
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.丹麦的一项观察性队列研究:感染 SARS-CoV-2 奥密克戎变异株与德尔塔变异株导致住院的风险比较。
Lancet Infect Dis. 2022 Jul;22(7):967-976. doi: 10.1016/S1473-3099(22)00154-2. Epub 2022 Apr 22.
3
Impact of prior vaccination on clinical outcomes of patients with COVID-19.
Registry-Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021-2024.
2021年至2024年挪威基于登记系统的严重急性呼吸道感染监测
Influenza Other Respir Viruses. 2025 Feb;19(2):e70080. doi: 10.1111/irv.70080.
4
Federated systems for automated infection surveillance: a perspective.联邦系统用于自动化感染监测:一个视角。
Antimicrob Resist Infect Control. 2024 Sep 27;13(1):113. doi: 10.1186/s13756-024-01464-8.
既往接种对 COVID-19 患者临床结局的影响。
Emerg Microbes Infect. 2022 Dec;11(1):1316-1324. doi: 10.1080/22221751.2022.2069516.
4
Acute Upper Airway Disease in Children With the Omicron (B.1.1.529) Variant of SARS-CoV-2-A Report From the US National COVID Cohort Collaborative.美国国家新冠队列协作组关于感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎(B.1.1.529)变异株儿童急性上呼吸道疾病的报告
JAMA Pediatr. 2022 Aug 1;176(8):819-821. doi: 10.1001/jamapediatrics.2022.1110.
5
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变异株的关系:一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
6
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.疫苗预防严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染和 COVID-19 疾病有效性的持续时间:系统评价和荟萃回归的结果。
Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23.
7
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.第二剂 COVID-19 疫苗接种后 9 个月内的感染、住院和死亡风险:瑞典的一项回顾性、全人群队列研究。
Lancet. 2022 Feb 26;399(10327):814-823. doi: 10.1016/S0140-6736(22)00089-7. Epub 2022 Feb 4.
8
Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter Study.COVID-19 突破性感染的影像学和临床特征:一项多中心研究。
Radiology. 2022 Jun;303(3):682-692. doi: 10.1148/radiol.213072. Epub 2022 Feb 1.
9
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.与德尔塔变异株相比,报告的 COVID-19 病例中感染 SARS-CoV-2 奥密克戎 BA.1 变异株的住院风险降低,挪威,2021 年 12 月至 2022 年 1 月。
Euro Surveill. 2022 Jan;27(4). doi: 10.2807/1560-7917.ES.2022.27.4.2200077.
10
Validity of ICD-10 codes for COVID-19 patients with hospital admissions or ED visits in Canada: a retrospective cohort study.加拿大新冠病毒疾病患者住院或急诊就诊时国际疾病分类第十版编码的有效性:一项回顾性队列研究
BMJ Open. 2022 Jan 21;12(1):e057838. doi: 10.1136/bmjopen-2021-057838.